MedPath

A Study for the management of infection in urine caused by bacteria E. coli with the help of herbal drugs.

Not Applicable
Conditions
Health Condition 1: N309- Cystitis, unspecified
Registration Number
CTRI/2021/06/034066
Lead Sponsor
RAIS UR RAHMA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

DIAGNOSED PATIENTS OF E. COLI INDUCED URINARY TRACT INFECTION (BY URINE CULTURE)

WILLING TO PARTICIPATE AND SIGN THE INFORMED UNDERSTOOD CONSENT FORM

Exclusion Criteria

PATIENTS WITH ANY ANATOMICAL ABNORMALITY OF URINARY TRACT, DIABETES MELLITUS, HEPATIC AND RENAL INSUFFICIENCY, PREGNANT AND LACTATING WOMEN, STDs AND HIV

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the safety and efficacy of the proposed Unani Polyherbal Formulation for the management of Urinary Tract Infection caused by E. coli.Timepoint: Clinical examination and subjective evaluation would be done at baseline, 7 day, 15 day, 30 day and 42 day. Safety evaluation will be performed and recorded at baseline, 7 day and 42 day. <br/ ><br>CBC, LFT & KFT would be done.
Secondary Outcome Measures
NameTimeMethod
To develop a safe, efficacious and cost-effective drug from a herbal source for the management of Urinary Tract Infection caused by E. coliTimepoint: For safety evaluation CBC, LFT & KFT would be done.
© Copyright 2025. All Rights Reserved by MedPath